Aclaris Therapeutics
Earnings Date & Report
Last updated:
Aclaris Therapeutics’s last earnings date was on 6 May 2024.
Aclaris Therapeutics stock Earnings report, Estimates & History
| 2019-11-07 | -0.57 | -1.34 |
|---|---|---|
| 2020-02-25 | -0.39 | -0.45 |
| 2020-05-07 | -0.32 | -0.37 |
| 2020-08-07 | -0.36 | -0.28 |
| 2020-11-04 | -0.3 | -0.25 |
| 2021-02-25 | -0.27 | -0.3 |
| 2021-05-07 | -0.29 | -0.57 |
| 2021-08-05 | -0.28 | -0.34 |
| 2021-11-02 | -0.28 | -0.35 |
| 2022-02-24 | -0.36 | -0.37 |
| 2022-05-10 | -0.4 | -0.31 |
| 2022-08-03 | -0.36 | -0.31 |
| 2022-11-08 | -0.4 | -0.3 |
| 2023-02-23 | -0.45 | -0.41 |
| 2023-05-08 | -0.44 | -0.42 |
| 2023-08-01 | -0.45 | -0.31 |
| 2023-08-02 | 0.45 | -0.31 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Aclaris Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 6 May 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 21 Feb 2024 | N/A | N/A | N/A | N/A | N/A | |
| 6 Nov 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Aug 2023 | Missed | $0.45 | -$0.31 | 1.9M | N/A | |
| 1 Aug 2023 | Beat | -$0.45 | -$0.31 | 1.9M | N/A | |
| 8 May 2023 | Beat | -$0.44 | -$0.42 | 1.75M | 2.52M | Earnings Call Transcript |
| 23 Feb 2023 | Beat | -$0.45 | -$0.41 | 1.99M | 7.75M | |
| 8 Nov 2022 | Beat | -$0.4 | -$0.3 | N/A | 19.01M | |
| 3 Aug 2022 | Beat | -$0.36 | -$0.31 | N/A | 1.52M | |
| 10 May 2022 | Beat | -$0.4 | -$0.31 | 1.77M | 1.45M | |
| 24 Feb 2022 | Missed | -$0.36 | -$0.37 | 1.79M | 1.50M | |
| 2 Nov 2021 | Missed | -$0.28 | -$0.35 | 1.77M | 1.65M | |
| 5 Aug 2021 | Missed | -$0.28 | -$0.34 | 1.75M | 1.82M | |
| 7 May 2021 | Missed | -$0.29 | -$0.57 | 1.72M | 1.77M | |
| 25 Feb 2021 | Missed | -$0.27 | -$0.3 | 1.40M | 1.58M | |
| 4 Nov 2020 | Beat | -$0.3 | -$0.25 | 1.69M | 1.44M | |
| 7 Aug 2020 | Beat | -$0.36 | -$0.28 | 2.63M | 2.04M | |
| 7 May 2020 | Missed | -$0.32 | -$0.37 | 1.21M | 1.40M | |
| 25 Feb 2020 | Missed | -$0.39 | -$0.45 | 949K | 1.09M | Earnings Call Transcript |
| 7 Nov 2019 | Missed | -$0.57 | -$1.34 | 853.65K | 983K | |
Aclaris Therapeutics Earnings report FAQs
When is Aclaris Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Aclaris Therapeutics's earnings date was on 1 Aug 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.